Sustained Remission of Lupus Panniculitis Treated With Hydroxychloroquine in a Patient With Crohn's Disease: A Case Report.
| Autor: | Zheng DD; Internal Medicine, Icahn School of Medicine at Mount Sinai, NYC Health + Hospitals/Queens, New York City, USA., Mantis J; Infectious Disease, Icahn School of Medicine at Mount Sinai, NYC Health + Hospitals/Queens, New York City, USA., Gurung DO; Internal Medicine, Icahn School of Medicine at Mount Sinai, NYC Health + Hospitals/Queens, New York City, USA., Abrudescu A; Rheumatology, Icahn School of Medicine at Mount Sinai, NYC Health + Hospitals/Queens, New York City, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2020 Sep 14; Vol. 12 (9), pp. e10455. Date of Electronic Publication: 2020 Sep 14. |
| DOI: | 10.7759/cureus.10455 |
| Abstrakt: | Extraintestinal manifestations (EIM) in inflammatory bowel disease (IBD) are common including cutaneous manifestations that either precede or follow manifestations of IBD. Cutaneous manifestations of IBD include erythema nodosum, pyoderma gangrenosum, oral lesions, and Sweet's syndrome. Cutaneous manifestations of IBD tend to recur and extensive cases may require maintenance management with immunomodulators or biologics. However, the complications and adverse effects of long-term therapy with immunosuppressive agents are numerous and need to be considered before their initiation. We report a case of a Crohn's disease patient with recurrent and debilitating cutaneous manifestation of lupus panniculitis that had sustained remission with hydroxychloroquine. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2020, Zheng et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|